Literature DB >> 23430941

Cardiac Pathology in Glycogen Storage Disease Type III.

S L Austin1, A D Proia, M J Spencer-Manzon, J Butany, S B Wechsler, P S Kishnani.   

Abstract

PURPOSE: To investigate the distribution and clinical impact of glycogen accumulation on heart structure and function in individuals with GSD III.
METHODS: We examined cardiac tissue and the clinical records of three individuals with GSD IIIa who died or underwent cardiac transplantation. Of the two patients that died, one was from infection and the other was from sudden cardiac death. The third patient required cardiac transplantation for end-stage heart failure with severe hypertrophic cardiomyopathy.
RESULTS: Macro- and microscopic examination revealed cardiac fibrosis (n = 1), moderate to severe vacuolation of cardiac myocytes (n = 3), mild to severe glycogen accumulation in the atrioventricular (AV) node (n = 3), and glycogen accumulation in smooth muscle cells of intramyocardial arteries associated with smooth muscle hyperplasia and profoundly thickened vascular walls (n = 1).
CONCLUSION: Our findings document diffuse though variable involvement of cardiac structures in GSD III patients. Furthermore, our results also show a potential for serious arrhythmia and symptomatic heart failure in some GSD III patients, and this should be considered when managing this patient population.

Entities:  

Year:  2012        PMID: 23430941      PMCID: PMC3565657          DOI: 10.1007/8904_2011_118

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  30 in total

1.  Nesiritide as bridge to multi-organ transplantation: a case report.

Authors:  A B Cochrane; S E Fedson; D C Cronin
Journal:  Transplant Proc       Date:  2007 Jan-Feb       Impact factor: 1.066

2.  Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.

Authors:  P Lee; M Burch; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy.

Authors:  H Akazawa; T Kuroda; S Kim; H Mito; T Kojo; K Shimada
Journal:  Eur Heart J       Date:  1997-03       Impact factor: 29.983

4.  Hepatocellular failure in glycogen storage disorder type 3.

Authors:  S A Ingle; N D Moulick; N U Ranadive; K Khedekar
Journal:  J Assoc Physicians India       Date:  2004-02

5.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

Authors:  Michael Arad; Barry J Maron; Joshua M Gorham; Walter H Johnson; J Philip Saul; Antonio R Perez-Atayde; Paolo Spirito; Gregory B Wright; Ronald J Kanter; Christine E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

6.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

Review 7.  Glycogen storage disease in adults.

Authors:  G M Talente; R A Coleman; C Alter; L Baker; B I Brown; R A Cannon; Y T Chen; J F Crigler; P Ferreira; J C Haworth; G E Herman; R M Issenman; J P Keating; R Linde; T F Roe; B Senior; J I Wolfsdorf
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

8.  QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  G Yi; P Elliott; W J McKenna; K Prasad; S Sharma; X H Guo; A J Camm; M Malik
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

9.  Electrocardiographic response to enzyme replacement therapy for Pompe disease.

Authors:  Annette K Ansong; Jennifer S Li; Eva Nozik-Grayck; Richard Ing; Richard M Kravitz; Salim F Idriss; Ronald J Kanter; Henry Rice; Y T Chen; Priya S Kishnani
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

10.  Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.

Authors:  Roddy McDowell; Jennifer S Li; Daniel Kelly Benjamin; Claire Morgan; Alison Becker; Priya S Kishnani; Ronald J Kanter
Journal:  Genet Med       Date:  2008-10       Impact factor: 8.822

View more
  14 in total

1.  Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease.

Authors:  Loren D M Pena; Alan D Proia; Priya S Kishnani
Journal:  JIMD Rep       Date:  2015-03-13

2.  Skeletal and cardiac muscle involvement in children with glycogen storage disease type III.

Authors:  Engy A Mogahed; Marian Y Girgis; Rodina Sobhy; Hala Elhabashy; Osama M Abdelaziz; Hanaa El-Karaksy
Journal:  Eur J Pediatr       Date:  2015-05-07       Impact factor: 3.183

3.  Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.

Authors:  Patrice Vidal; Serena Pagliarani; Pasqualina Colella; Helena Costa Verdera; Louisa Jauze; Monika Gjorgjieva; Francesco Puzzo; Solenne Marmier; Fanny Collaud; Marcelo Simon Sola; Severine Charles; Sabrina Lucchiari; Laetitia van Wittenberghe; Alban Vignaud; Bernard Gjata; Isabelle Richard; Pascal Laforet; Edoardo Malfatti; Gilles Mithieux; Fabienne Rajas; Giacomo Pietro Comi; Giuseppe Ronzitti; Federico Mingozzi
Journal:  Mol Ther       Date:  2017-12-28       Impact factor: 11.454

4.  Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Authors:  Elizabeth D Brooks; Haiqing Yi; Stephanie L Austin; Beth L Thurberg; Sarah P Young; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

5.  Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III.

Authors:  Alessandra Brambilla; Savina Mannarino; Roberta Pretese; Serena Gasperini; Cinzia Galimberti; Rossella Parini
Journal:  JIMD Rep       Date:  2014-10-12

6.  Histopathological substrate of the atrial myocardium in the progression of obstructive sleep apnoea-related atrial fibrillation.

Authors:  Ling Zhang; Kun Ye; Jiasuoer Xiaokereti; Mei Ma; Yankai Guo; Xianhui Zhou; Baopeng Tang
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

7.  Glycogen storage disease type III: modified Atkins diet improves myopathy.

Authors:  Sebene Mayorandan; Uta Meyer; Hans Hartmann; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-11-28       Impact factor: 4.123

Review 8.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

9.  Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts.

Authors:  Ying Ann Chiao; Stephen C Kolwicz; Nathan Basisty; Arni Gagnidze; Julia Zhang; Haiwei Gu; Danijel Djukovic; Richard P Beyer; Daniel Raftery; Michael MacCoss; Rong Tian; Peter S Rabinovitch
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 10.  Biomarkers in Glycogen Storage Diseases: An Update.

Authors:  Alberto Molares-Vila; Alberte Corbalán-Rivas; Miguel Carnero-Gregorio; José Luís González-Cespón; Carmen Rodríguez-Cerdeira
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.